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Abstract—Amyotrophic lateral sclerosis (ALS) leads to a loss of specific motor neuron populations in the spinal
cord and cortex. Emerging evidence suggests that interneurons may also be affected, but a detailed characteri-
zation of interneuron loss and its potential impacts on motor neuron loss and disease progression is lacking.
To examine this issue, the fate of V1 inhibitory neurons during ALS was assessed in the ventral spinal cord using
the SODG93A mouse model. The V1 population makes up 30% of all ventral inhibitory neurons, 50% of direct
inhibitory synaptic contacts onto motor neuron cell bodies, and is thought to play a key role in modulating motor
output, in part through recurrent and reciprocal inhibitory circuits. We find that approximately half of V1 inhibitory
neurons are lost in SODG93A mice at late disease stages, but that this loss is delayed relative to the loss of motor
neurons and V2a excitatory neurons. We further identify V1 subpopulations based on transcription factor expres-
sion that are differentially susceptible to degeneration in SODG93A mice. At an early disease stage, we show that
V1 synaptic contacts with motor neuron cell bodies increase, suggesting an upregulation of inhibition before V1
neurons are lost in substantial numbers. These data support a model in which progressive changes in V1 synaptic
contacts early in disease, and in select V1 subpopulations at later stages, represent a compensatory upregulation
and then deleterious breakdown of specific interneuron circuits within the spinal cord.
This article is part of a Special Issue entitled: A Commemoration of Thomas M. Jessell’s Contributions to Neuroscience.
 2020 The Author(s). Published by Elsevier Ltd on behalf of IBRO. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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susceptibility.INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a
neurodegenerative disease that is characterized by the
adult-onset degeneration of motor neurons in the spinal
cord and cortex. As disease progresses, patients suffer
from increasingly severe motor deficits and eventual
fatal paralysis (Hardiman et al., 2017). While motor neu-
ron loss is a defining characteristic of ALS, the extent to
which other components of motor circuitry are similarly
affected or undergo compensatory changes remains
unclear. A better understanding of the underlying cellular
and circuit mechanisms of disease progression may be
key in devising new treatments to prevent or slow ALS
pathology.https://doi.org/10.1016/j.neuroscience.2020.08.011
0306-4522/ 2020 The Author(s). Published by Elsevier Ltd on behalf of IBRO.
This is an open access article under the CC BY-NC-ND license (http://creativecomm
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Abbreviations: ALS, amyotrophic lateral sclerosis; CS, clinical score;
SOD1, superoxide dismutase 1.
81Studies of the genetics underlying ALS have revealed
that ALS-associated genes span many functional classes
but together fail to reveal a common underlying
mechanism of disease, suggesting that ALS is a
syndrome with a complex etiology involving multiple
pathways (Al-Chalabi and Hardiman, 2013). The first-
identified ALS-associated gene, superoxide dismutase 1
(SOD1), has nonetheless been a focus of study, as muta-
tions in this gene are associated with both familial (20%)
and sporadic (5%) disease (Kaur et al., 2016). Transgenic
mice expressing multiple copies of the SOD G93A mutant
allele (hereafter referred to as SODG93A mice) phenocopy
many of the neurological symptoms and cellular pathology
seen in ALS patients, making this mouse line a valuable
model to study ALS onset and progression (Lutz, 2018).
This progression has been defined by clinical score (CS,
Solomon et al., 2011): an early stage (CS1–2; postnatal
days 85–110), when SODG93A mice first exhibit shaking
and splaying of the limbs followed by deficits in stride and
gait; a mid-stage (CS3–4; postnatal days 110–130), whenons.org/licenses/by-nc-nd/4.0/).
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stage (CS5; postnatal days 130–145), when quadriplegia
and death typically occur (Gurney et al., 1994).
This progressive loss of motor function in ALS is
accompanied by a prominent but selective loss of motor
neurons, a feature that has historically defined the
disease. In SODG93A mice, this loss becomes more
severe with time, with a 30% reduction in motor neuron
number by early and a 70% reduction by late stages of
disease (Chiu et al., 1995). Even at pre-symptomatic
stages, motor neurons exhibit changes in electrical prop-
erties and synaptic transmission, disrupted axon trans-
port, and cellular stress and caspase activation
(reviewed in van Zundert et al., 2012). The prominent loss
of motor neurons in both human and mouse models of
ALS (Kanning et al., 2010), however, is selective, with
certain motor neurons subtypes showing a marked sus-
ceptibility and others not. Alpha motor neurons, which
drive skeletal muscle contraction, are lost in high numbers
over the course of disease, while gamma motor neurons,
which innervate muscle spindles and modulate muscle
sensitivity, do not decrease in number, even at late stages
of disease (Kaplan et al., 2014; Lalancette-Hébert et al.,
2016; Morisaki et al., 2016). Moreover, alpha motor neu-
rons themselves exhibit differences in susceptibility to
degeneration, with the fast-fatigue subtype the most sus-
ceptible, the fast-fatigue-resistant subtype less so, and
the slow subtype the least susceptible (Frey et al.,
2000; Fischer et al., 2004; Pun et al., 2006). The underly-
ing cause of these differences in susceptibility is not
known but could be due to differences in the intrinsic
physiology or connectivity of motor neuron subtypes.
While motor neuron pathology is thought to make a
large contribution to ALS disease onset, dysfunction of
other spinal neurons is likely to contribute to disease
progression. In human ALS patients, spinal
interneurons, defined cytologically, are lost in significant
numbers (Stephens et al., 2006), while in ALS mouse
models, interneuron losses have begun to be mapped to
defined subsets (van Zundert et al., 2012; Brownstone
and Lancelin, 2018). In SODG93A mice, inhibitory neurons,
identified broadly by the expression of the neurotransmit-
ters, GlyT2 and Gad67, upregulate pathological markers
of stress and downregulate neurotransmitter expression,
(Hossaini et al., 2011). Renshaw cells, a small subpopu-
lation of inhibitory neurons that participate in direct recur-
rent inhibition of motor neurons, first increase their
synaptic contacts onto motor neurons in a proposed com-
pensatory manner and then themselves decrease in num-
ber at very late disease stages (Wootz et al., 2013).
Excitatory neurons also show a marked decrease in num-
bers in SODG93A mice, with loss of the V2a population
matching both the extent and timing of motor neuron loss
(Romer et al., 2017). Finally, synapses derived from the
cholinergic V0c population are found first to be enlarged
and then lost during disease progression (Chang and
Martin, 2009; Pullen and Athanasiou, 2009; Herron and
Miles, 2012), with functional inactivation of this subpopu-
lation in ALS mice affecting motor performance (Landoni
et al., 2019; Konsolaki et al., submitted). These lines of
evidence increasingly point to a disruption of interneuroncircuits in ALS progression, and raise the question of what
the mechanistic relationship is between motor neuron
loss, interneuron loss and disease stage.
To address this question, a more detailed
understanding is needed of how the different classes of
spinal interneurons are affected during ALS. Accordingly,
we focused on the ventral V1 inhibitory class of neurons,
which are derived from a common progenitor domain
that gives rise to 30% of all the ventral inhibitory
neurons in the spinal cord, and comprise 50% of the
total inhibitory synaptic contacts onto motor neurons
(Zhang et al., 2014). This V1 class includes the well-
studied Ia- inhibitory (13% of total V1) and Renshaw cell
(9% of total V1) subpopulations (Alvarez et al., 2005),
which coordinate antagonistic muscle pairs and mediate
recurrent inhibition, respectively (Gosgnach et al., 2017).
In addition, V1 interneurons can be further parsed molec-
ularly into distinct subpopulations based on combinatorial
transcription factor expression (Bikoff et al., 2016; Gabitto
et al., 2016; Sweeney et al., 2018). This recent analysis
suggests that the V1 population at all spinal cord levels
can be assigned to four groups, termed clades, with
emerging evidence of clade-specific expression, connec-
tivity and functional properties. Each clade can be further
subdivided into multiple subtypes based on their unique
expression of different combination of transcription fac-
tors, raising the possibility these represent diverse func-
tional subtypes required for motor output at each spinal
cord level (Francius et al., 2013; Bikoff et al., 2016;
Gabitto et al., 2016; Sweeney et al., 2018). We reasoned
that this diversity makes the V1 population an ideal class
to examine whether interneuron subtypes are differentially
susceptible to ALS progression. Conversely, since the sig-
nificance of V1 genetic diversity has yet to be fully
explored, such analysis of V1 subsets in the context of
ALS provides an opportunity to test whether these repre-
sent different functional populations.
We assess the number of V1 inhibitory neurons in
control and SODG93A mice during disease progression,
using a genetic tracer. At late stages of disease, we find
that 40% of V1 inhibitory neurons on average are lost in
SODG93A mice, compared with an approximately 60%
loss of motor neurons, 60% loss of V2a excitatory
neurons, and limited or no loss of other ventral, NeuN+
neurons. This result supports a preferential loss of V1
and V2a compared with other V0, V2b and V3 ventral
classes of interneurons. At early stages of disease, we
find that V1 inhibitory neurons are less affected than
motor and V2a excitatory neurons, demonstrating that
V1 loss is a later feature of disease. We further find that
V1 inhibitory neurons fall into ALS- susceptible or
resistant subpopulations, analogous to the differential
susceptibility of motor neuron subtypes. Finally, at early
stages of disease before V1 inhibitory neurons are lost
in large numbers, we show that V1 synaptic contacts
increase on ventral motor neuron cell bodies undergoing
stress and death. This increase is consistent with but
exceeds that previously observed for Renshaw cells
(Wootz et al., 2013). Together these results reveal a gen-
eralized early increase in V1 to motor neuron synaptic
contacts, and a subsequent selective loss of V1 subpop-
A. Salamatina et al. / Neuroscience 450 (2020) 81–95 83ulations. Such alterations in V1 circuits may point to a
broader role of interneurons in modulating the progres-
sion and severity of ALS.EXPERIMENTAL PROCEDURES
Animals
All experiments and procedures were performed
according to NIH guidelines and approved by the
Institutional Animal Care and Use Committee of the
Salk Institute for Biological Studies. The following
previously published mouse strains were used in this
study: B6SJL-Tg(SOD1*G93A)1Gur/J, SODG93A
(Gurney et al., 1994), En1::Cre (Sapir et al., 2004),
and B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J
(otherwise known as Ai14; Madisen et al., 2010). Geno-
typing was performed using ExTaq DNA Polymerase
(Takara, RR001C) and manufacturer’s recommended
PCR conditions with the following primers and annealing
temperatures: SODG93A offspring with primers oIMR113
and oIMR114 (Jackson Laboratory, Bar Harbor, MI,
USA) at an annealing temperature of 60 C, En1::Cre off-
sping with Cre 1 (50-CCGGTGAACGTGCAAAA
CAGGCTCTA-30) and Cre 2 (50-CTTCCAGGGCGC
GAGTTGATAGC-30) primers at an annealing temperature
of 59 C, and Ai14 offspring with a combination of Rosa 4
(50-TCAATGGGCGGGGGTCGTT-30), 10 (50-CTCTGCT
GCCTCCTGGCTTCT-30), and 11 (50-CGAGGCGGATCA
CAAGCAATA-30) primers at an annealing temperature of
66 C. Age- and gender-matched control or SODG93A lit-
termates expressing En1::Cre and Ai14 were used for
analysis. Animals were sacrificed at early (clinical score
1–2, CS1-2; abnormal splay of the hindlimbs and tremors
when lifted by the tail; average age = 110 ± 4 days) or
late (clinical score 5, CS5; significant paralysis such that
they are unable to right themselves after 30 seconds;
average age = 124 ± 7 days) disease stages, in accor-
dance with standardized phenotyping criteria defined in
Solomon et al., 2011. Control and experimental mice were
maintained on a congenic B6SJLF1/J background. Near
equal numbers of female and male mice were analyzed
for all experiments and were maintained using standard
husbandry and housing conditions.Immunohistochemistry
Mice were anesthetized and subsequently perfused with
1 PBS and then 4% paraformaldehyde. The spinal
cord was then dissected out, post-fixed in 4% PFA for
two hours at 4 C, washed with 1 PBS, and immersed
in 30% sucrose for at least 12 h, until equalized, before
being frozen in Tissue-Tek OCT Compound (Sakura).
Cryostat sections (25 mm) were washed with 1X PBS
with 0.2% Triton (PBT), incubated with 10% donkey
serum (Millipore) in PBT for one hour at room
temperature, and then primary antibody in PBT plus
10% donkey serum overnight at 4 C. Sections were
then rinsed with PBT, incubated with secondary
antibody in PBT plus 10% donkey serum for 30 min at
room temperature, washed in PBT, incubated with
DAPI, mounted in PVA/DABCO, and coversliped forimaging. Images were obtained on either a LSM 710 or
780 microscope (Zeiss) at a 512  512 or greater
resolution using a Plan-Aprochromat 20/0.8 M27
objective (visualization of neurons) or a LSM 880 Rear
Port Laser Scanning Confocal with an Airyscan FAST
module (visualization of synapses).
Primary antibodies used were as follows: goat anti-
Choline Acetyl-Transferase (ChAT, 1:200, Millipore
Sigma, #AB144P), guinea pig anti-Chx10 (Hayashi
et al., 2018), rabbit anti-NeuN (1:1000, Millipore Sigma,
#ABN78), rabbit anti-ATF3 (1:2000, Millipore Sigma,
#HPA001562), rabbit anti-cleaved Caspase 3 (cCasp3,
1:150, Cell Signaling Technology, #9661), goat anti-
FoxP2 (1: 1000, Santa Cruz Biotechnology N-16, sc-
21069), goat anti-Sp8 (1:500, Santa Cruz Biotechnology,
C-18, sc-104661), rat anti-Pou6f2 (Jessell Lab, RRID:
AB_2665427), rabbit anti-Calbindin D28K (1:2000,
Swant, #CB38), rabbit anti-Nr4a2/Nurr1 (1:500; Santa
Cruz Biotechnology, M-196, sc-5568), and guinea pig
anti-VGAT (1:1000; Synaptic Systems, #131 004). Don-
key anti-goat, anti-guinea pig, anti-rabbit, and anti-rat
fluorescent-conjugated secondary antibodies (1:500;
Green: Alexa Fluor 488; Red: Cy3 or DyLight 549; and
Far-red: Cy5, Alexa Fluor 647 or DyLight649) were
obtained from Jackson ImmunoResearch and DAPI from
Sigma (1:400; D9542).Quantification of spinal neuron number and spatial
distribution
To determine the number and distribution of neurons in the
spinal cord, confocal images were imported into Imaris
(Bitplane) and spots were assigned to the nucleus of
each neuron either manually or using the ‘‘Spots” function
followed by manual validation. Thresholds were set to
exclude non-specific background immunoreactivity. For
transcription factor analysis, variations in levels of
expression were not taken into consideration, resulting in
a determination of ‘‘expressed” or ‘‘not expressed.”
Analysis of the spatial position of each cell body, or spot,
was performed as previously described (Bikoff et al.,
2016; Gabitto et al., 2016). In short, Cartesian coordinates
for each neuron were determined in the transverse spinal
cord plane with respect to themidpoint of the central canal,
defined as position (0,0), and the lateral and ventral-most
edge of the gray matter. The compiled data from all hemi-
sections analyzed was then morphed onto a standardized
hemi-section that reflected the lumbar spinal cord shape
at postnatal day zero (distance from central canal to lateral
edgewas650 mmanddistance fromcentral canal to ventral
edgewas 400 mm)or postnatal day 120 (distance fromcen-
tral canal to lateral edge was 840 mm and distance from
central canal to ventral edge was 570 mm) levels. Spatial
contour analysis was performed as previously described
(Bikoff et al., 2016). Related MATLAB codes are available
at https://github.com/BPHO-Salk/DifferentialLoss_ALS.
git.Analysis of cell body synaptic contacts
The cell bodies of motor neurons and the neurites of V1
inhibitory neurons were labeled with ChAT
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expression, respectively. To determine the number of
V1 synaptic contacts with a given motor neuron, a
1560  1560 pixel resolution image z-stack image was
acquired with a 0.2 mm z-step via an AIRYscan LSM
880 confocal microscope with a Plan-Apochromat
63/1.4 Oil DIC M27 lens (Zeiss). Seven consecutive
sections at the level of the nucleolus were analyzed and
on the single, middle section, the number of synaptic
contacts with the motor neuron cell body or proximal
dendrites per mm of the neuron’s circumference were
scored according to the following criteria: (1) a
TdTomato-positive synaptic enlargement adjacent to the
cell body or proximal dendrite that spanned at least 3
consecutive sections and (2) the presence of a
contiguous TdTomato-positive V1 neuronal process in
one or more sections adjacent to the enlarged synaptic
contact. In control experiments (see Fig. S5), VGAT
antibody co-labeling was used to validate that such
TdTomato-positive enlargements with a contiguous
neurite were synaptic contacts. The cell body
circumference of a given motor neuron was determined
by tracing its perimeter using Imaris measurement
points tool.Quantification and statistical analyses
All statistical analyses are detailed in figure legends and
supplementary Table S1. For each littermate control and
SOD mouse, parallel sections were collected every
25 mm over an identical rostro-caudal segment of the
lumbar (L3–5), thoracic (T4–6) or brachial (C4–6) spinal
cord. Individual sections were then imaged at varying
but evenly spaced intervals within this segment—with
the first image being the most rostral and the last image
being the most caudal. For each animal, an average
neuron number per section was then calculated from all
sections imaged. For a given number of animal pairs
(n= animals), these animal averages were then used
for all subsequent statistical analyses. Normality was
tested across animal pairs with either a Kolgomorov–
Smirnov (large n) or a Shapiro–Wilk (small n) test as
appropriate. For normally distributed data, significance
of differences between animal means were compared
with a two-tailed Student’s t or one-way ANOVA plus
post-hoc Tukey (parametric). For all other non-normal
data, a Mann–Whitney or Kruskal–Wallis plus Dunn’s
(non-parametric) test was performed. All data are
represented as the mean ± sem for a given number of
animals, unless otherwise noted.RESULTS
Spinal motor and interneuron loss at late stages of
ALS
To examine differential neuron loss in the ventral spinal
cord during ALS, we scored V1 inhibitory, V2a
excitatory, motor and total neurons in SODG93A mice
(Gurney et al., 1994) at late stages of disease (Figs. 1A
and S1A). This late stage timepoint was defined by the
inability of SODG93A mice to right themselves after thirtyseconds, the well-established, phenotyping criteria of clin-
ical score 5 (CS5, also referred to as late stage; average
age = 124 ± 7 days; (Solomon et al., 2011). V1 inhibi-
tory neurons were genetically marked by En1::Cre
(Sapir et al., 2004) and the CAG.lsl.tdTomato reporter
allele (Ai14; Madisen et al., 2010). Other neuronal popu-
lations were scored based on antibody reactivity for
established markers of cell type identity: V2a excitatory
neurons express Chx10 (Ericson et al., 1997; Crone
et al., 2008; Hayashi et al., 2018), and motor neurons
express ChAT. NeuN expression was used as a rough
measure of total neurons, although restricted expression
in some classes like motor neurons (see below) can be
used to define subtypes.
We focused our analysis on the lumbar L3–L5 spinal
cord and analyzed a representative set of spinal cord
sections from SODG93A mice along with their age- and
gender- matched littermate controls. As previously
shown (Gurney et al., 1994; Chiu et al., 1995), we found
that 58% of the lumbar motor neurons were lost at CS5
(Fig. 1B), with both those located in the lateral (61%)
and medial (55%) halves of the spinal cord equally
affected (Fig. S1B, C). Motor neurons in the lumbar spinal
cord have been reported to vary in their susceptibility, with
muscle fiber-innervating alpha motor neurons being the
most susceptible, and muscle spindle-innervating gamma
motor neurons being the least susceptible (Lalancette-
Hébert et al., 2016). We similarly found that alpha motor
neurons (ChAT+ NeuN+ with a large cell body perimeter)
were markedly reduced in SODG93A mice at CS5, while
gamma motor neurons (ChAT+ NeuN with a small cell
body perimeter) were unaffected (Fig. S1D–F). In addi-
tion, and in agreement with Romer et al. (2017), we found
that V2a excitatory interneurons were reduced by 57% in
SODG93A compared with control mice (Fig. 1D). Based on
the substantial losses of both motor and excitatory neu-
rons, we explored whether inhibitory neurons might be
similarly affected in SODG93A mice at this late disease
stage.
Analysis of the number of V1 inhibitory neurons,
indelibly marked by En1::Cre expression, revealed a
39% reduction in SODG93A compared to control mice
(Fig. 1C). By contrast, no significant difference was
detected in the same control and SODG93A mice in the
total number of ventral NeuN+ neurons, after excluding
motor and V1 inhibitory neurons and because V2a
excitatory neurons comprise a minor component of the
total (Fig. 1E). In summary, we find that a significant
fraction of V1 inhibitory neurons are lost at late stages
of disease, and that this loss in combination with that of
motor neurons and V2a excitatory neurons is greater
than that of other neurons in the ventral spinal cord.
Spinal motor and interneuron loss at early stages of
ALS
Previous studies have demonstrated that inhibitory
neurons are unaffected at presymptomatic stages of
disease (Hossaini et al., 2011), raising the question of
when the V1 losses we observe occur. To explore the pro-
gression of subtype-specific neuronal loss in ALS, we
examined SODG93A mice at a symptomatic but early
















Fig. 1. Neuronal loss at late stages of disease in the SODG93A mouse model of ALS. (A) Hemi-sections of the ventral L3–L5 spinal cord of a control
(CTL, left) and a CS5 SODG93A (SOD, right) mouse were stained for markers of motor (ChAT+, green), V1 inhibitory (En1.TdT+, red), and total
NeuN+ neurons (blue). ChAT+NeuN+, cyan. En1.TdT+NeuN+, magenta. Scale bar = 100 mm. (B–E) Ventral neuron loss in the lumbar spinal
cord of CS5 SODG93A mice versus littermate controls: motor neurons ((B): P < 0.0001, 59% decrease), V1 inhibitory neurons ((C): P< 0.0001,
39% decrease), V2a excitatory neurons ((D): P= 0.0019, 57% decrease), and ventral NeuN-positive neurons excluding motor and V1 inhibitory
neurons ((E): P= 0.4345, no decrease). In the scatter dot plots shown here and in subsequent Figures, each point represents the average neuron
number per 25 lm lumbar hemi-section based on multiple sections from a given animal, where the number of sections analyzed for each animal is
provided in Table S1. The number of points represents the number of SODG93A and control littermate pairs analyzed. Ventral cell body position was
defined as below the midpoint of the central canal. P values were determined by a Mann–Whitney (B) or an unpaired, two-tailed t-test (C–E) as
appropriate (***P< 0.001; **P < 0.01; *P< 0.05). All subsequent statistical analyses are detailed in Experimental Procedures and Supplementary
Table S1.
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also referred to as early stage; average age = 110
± 4 days). At this stage, mice display hyperflexion of
the hindlimbs when suspended by the tail but no other
movement deficits during the locomotor step cycle
(Solomon et al., 2011). Previously, it has been found that
only the most highly susceptible, alpha fast-fatigue motor
neurons, which make up approximately one third of the
total, are lost at this stage, while other motor neurons
are still present (Lalancette-Hébert et al., 2016). V2a exci-
tatory neurons similarly are less affected at this earlier dis-
ease stage in SODG93A mice, with only a 20% loss in V2a
neuron number (Romer et al., 2017). Consistent with
these previous results, in the lumbar spinal cord of CS1-
2 SODG93A mice compared to control littermates (Fig. 2-
A-–D), we found that the number of motor neurons
(Fig. 2C) and V2a excitatory neurons (Fig. 2D) are
decreased on average by 39% and 29%, respectively.
In contrast, V1 inhibitory neurons were reduced by
only 13% at this earlier disease stage (Fig. 2E). To
examine the relationship between the differential loss of
neuron types within a given animal, we scored V1inhibitory, V2a excitatory, and motor neuron numbers in
adjacent spinal cord sections from pairs of gender- and
aged-matched control and SODG93A littermates. We
then plotted these data at early (CS1-2) and late (CS5)
stages to compare the proportional magnitude of loss of
each neuronal population between animals and over
disease progression (Fig. 2F–H and Table S1). Across
individual animal pairs and disease stages, motor, V2a
and V1 losses were well-correlated, demonstrating a
potential relationship between loss of these
interconnected neuron types. However, the extent of
loss varied with motor and V2a loss occurring in a near
one-to-one ratio (Fig. 2F) and consistently greater than
V1 loss (Fig. 2G, H).
To examine further whether the pathology of V1
inhibitory neurons is less advanced than motor neurons
at early stages, we labeled lumbar sections of CS1–2
SODG93A mice with antibodies against the cell stress
marker, ATF3 (Fig. S2A–C) and the cell death marker,
cleaved Caspase 3 (cCasp3; Fig. S2D–F). At late
stages of disease, both ATF3 and cCasp3 are detected
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A. Salamatina et al. / Neuroscience 450 (2020) 81–95 87et al., 2000; Hossaini et al., 2011). However, at CS1–2,
while motor neurons that express these markers were
readily observed, very little expression was detected in
V1 inhibitory neurons in the same section, providing addi-
tional support that motor neurons are more advanced in
their degeneration than V1 inhibitory neurons at this
stage. Together these data suggest that a subset of V1
inhibitory interneurons are lost in ALS but that V1 degen-
eration occurs after that of motor neurons and V2a excita-
tory neurons.Clade analysis of inhibitory V1 subtypes in ALS
V1 inhibitory neurons can be subdivided by their
physiological and molecular properties, leading to the
view that the V1 class is comprised of numerous
transcriptionally, anatomically and electrophysiologically
diverse subpopulations (Gosgnach et al., 2017). Since
only a third of the total V1 population has degenerated
in SODG93A mice even at late stages of disease, we
examined whether V1 subpopulations were differentially
affected. To address this issue, we first tested whether
the transcription factors that subdivide V1 inhibitory neu-
rons at an early postnatal stage also mark similar subpop-
ulations in the adult spinal cord.
We focused our analysis on the four major subgroups
of V1 inhibitory neurons, termed clades, which are defined
by the mutually exclusive expression of the transcription
factors FoxP2, Sp8, Pou6f2, and MafA; include greater
than 50% of all V1 inhibitory neurons; and differ in their
connectivity and electrophysiological properties (Bikoff
et al., 2016; Gabitto et al., 2016). Antibodies against Fox-
p2, Sp8 and Pou6f2 labeled subsets of V1 inhibitory neu-
rons in the adult (p120–140) (Fig. 3A). MafA staining,
which primarily marks Renshaw cells at p0, was not
detected in the adult, and thus Calbindin immunoreactivity
coupled with ventral cell body position was instead used
as a Renshaw cell marker (Benito-Gonzalez and
Alvarez, 2012). Strikingly, the percentages of V1 inhibi-
tory neurons (indicating clade size) labeled with these four
markers were similar at adult stages (Fig. 3B-–E) to those
observed at p0 (Bikoff et al., 2016; Sweeney et al., 2018).
Furthermore, at both early postnatal and adult time points,
these clade markers showed zero overlap (data not
shown), together included more than 50% of all V1 inhibi-
tory neurons, and individually each labeled V1 subpopula-
tions with a spatially-distinct but temporally-conserved
settling position (Fig. 3B-–E). Such differences in position
between clades but similarities between stages can be
most readily observed in the dorsomedial, dorsolateral,
and ventral positioning of the V1Sp8 (Fig. 3C), V1Pou6f2Fig. 2. Lumbar motor and interneuron loss at disease onset. (A, B) Hemi-se
CS1–2 SODG93A (SOD, right) mouse were stained for markers of either moto
inhibitory (En1.TdT+, red) neurons. Scale bar = 100 mm. (C–E) Ventral ne
littermate controls: motor neurons ((C): P< 0.0001, 40% decrease), V2a e
neurons ((E): P= 0.008, 13% decrease). Scatter dot plots represent average
in the legend to Fig. 1. (F–H) Animal-by-animal comparisons of motor neur
CS1–2 (green) and CS5 (red) SODG93A mice: Motor versus V2a excitator
neurons ((G): slope = 0.67; R2 = 0.35), and V2a excitatory versus V1 inhibi
percent decrease in mean SOD vs. CTL neuron number for a single litterma(Fig. 3D), and V1vCalbindin (Fig. 3E) subpopulations,
respectively. These results indicate that transcription fac-
tor expression continues to track the V1 clades into adult
stages, further supporting that the clade designation is
likely to have functional significance for mature V1
interneurons.
Such persistence of transcription factor expression
also provides a tool to examine the susceptibility of
each clade to degeneration in SODG93A mice at late
CS5 stages of disease. We found that the most
dramatic reduction occurred in the V1FoxP2 clade
(Fig. 3F, 51%), with a smaller but significant reduction in
the V1Sp8 clade (Fig. 3G, 38%) and no significant
change in the V1Pou6f2 (Fig. 3H) or V1Calbindin (Fig. 3I)
clades. To address the possibility that such differences
in susceptibility may in part result from differences in
clade size, we performed power analyses. For all
clades, we had sufficient power to detect 30% or
greater changes in cell number, indicating that
undetected changes in V1Pou6f2 or V1Calbindin clades are
likely to be small or non-existent. These data indicate
that V1 loss differs in magnitude between clades,
suggesting that V1 inhibitory neurons, like motor
neurons, fall into ALS-susceptible and ALS-resistant
subpopulations.Combinatorial analysis of V1 subsets in ALS
Within clades, V1 inhibitory neurons can be further
classified into smaller subsets by the combinatorial
expression of transcription factors (Bikoff et al., 2016;
Gabitto et al., 2016; Sweeney et al., 2018). Like the
clades, these smaller subsets may represent functionally
distinct subpopulations, rendering them differentially sus-
ceptible to ALS. To begin to address this issue, we
focused our analysis on the V1FoxP2 clade because it is
the largest and the most affected, and surveyed the
expression of transcription factors that subdivide it at
early postnatal stages (Bikoff et al., 2016). We found that
Nr4a2 expression was maintained until adult stages,
and divided the FoxP2 clade into a Nr4a2-OFF
(V1FoxP2+Nr4a2, 75% of the clade) and Nr4a2-ON
(V1FoxP2+Nr4a2+, 25% of the clade) subpopulation, similar
to what has been observed at p0 (Fig. 3J, K),. This similar
pattern of Nr4a2 expression at postnatal and adult stages
lends support to the functional importance of these tran-
scriptional distinctions within a clade
We further evaluated these clade-derived V1 subsets
in ALS at the late CS5 stage of disease. We find in
SODG93A mice that the V1FoxP2+Nr4a2+ inhibitory
neurons are reduced in number by 78% (Fig. 3N), whilections of the ventral L3–L5 spinal cord of a control (CTL, left) and a
r ((A): ChAT+, green) or V2a excitatory ((B): Chx10+, green) and V1
uron loss in the lumbar spinal cord of CS1–2 SODG93A mice versus
xcitatory neurons ((D): P= 0.004, 29% decrease), and V1 inhibitory
neuron number per 25 lm lumbar hemi-section as described in detail
on, V1 inhibitory, and V2a excitatory neuron loss at lumbar levels in
y neurons (F: slope = 1.04; R2 = 0.55), motor versus V1 inhibitory
tory neurons ((H) slope = 0.62; R2 = 0.70). Each dot represents the









































Fig. 3. Differential loss of V1 inhibitory neuron clades in CS5 SODG93A mice. (A) Sections of lumbar level spinal cord from p120 control mice,
stained for V1 inhibitory neurons (Red: En1.TdT) and with antibodies (green) against FoxP2, Sp8, Pou6f2 or Calbindin. Panels above show a right
hemi-segment, while insets below show overlap and individual channels for a subset of neurons. Scale bar = 100 mm. (B–E) V1 clade markers are
expressed in similar percentages of V1 inhibitory neurons in early postnatal (P0) and adult (P120) mice. Graphs depict percentage (above), and
spatial plots depict position (below), of V1 inhibitory neurons marked by En1.TdT lineage trace and FoxP2 ((B), V1FoxP2), Sp8 ((C), V1Sp8), Pou6f2
((D), V1Pou6f2) and Calbindin ((E), V1vCalbindin) antibodies. Spatial plots depict 20th–80th percentile density contours as described in Sweeney et al.
(2018) and Experimental Procedures. The Renshaw cell clade is defined as Calbindin-expressing V1 neurons in the ventral-most 20% of the spinal
cord. (F–I) Quantification of V1 clade susceptibility. V1FoxP2 ((F): P< 0.001, 49% decrease) and V1Sp8 ((G): P= 0.0087, 45% decrease) inhibitory
neurons are the most susceptible, while V1Pou6f2 ((H): P = 0.1975) and V1vCalbindin ((I): P= 0.3603) inhibitory neurons were unaffected at CS5.
Scatter dot plots represent average neuron number per 25 lm lumbar hemi-section as described in the legend in Fig. 1. Power analyses based on
average and standard deviation measurements indicates 8 animals are sufficient to detect a 30% loss in SOD compared to control animals for all V1
clades. (J, K) Nr4a2 transcription factor expression (blue) further subdivides FoxP2-expressing (green) V1 inhibitory neurons (red) into a Nr4a2-on
and Nr4a2-off subpopulation at adult stages in control animals (J). Panels above show a right hemi-segment, while insets below show individual
channels and overlap for a subset of neurons. These subpopulations are of similar proportions at P0 (black) and adult (P120, gray) stages (K). Scale
bar = 100 mm. (L–N)Within the V1FoxP2 clade, the V1FoxP2+Nr4a2+ subpopulation is particularly susceptible at CS5 to neuron loss ((N): P= 0.0002,
78% decrease), compared with the parental V1FoxP2 ((L): P= 0.0120, 52% decrease) or V1FoxP2+Nr4a2 subpopulation ((M): P= 0.0262, 47%
decrease). Scatter dot plots represent average neuron number per 25 lm lumbar hemi-section as described in the legend of Fig. 1.
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(Fig. 3M) are only reduced by half. Thus, a smaller
clade-derived subset, like the clades themselves, canvary in their susceptibility, further supporting a model in
which specific V1 microcircuits may be differentially lost
during disease progression. One implication of this
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inhibitory neurons (Benito-Gonzalez and Alvarez, 2012),
suggesting that the dramatic losses we observe for speci-
fic FoxP2 subsets might reflect a potential disruption of
reciprocal inhibitory circuits in ALS.
Spinal interneuron susceptibility in ALS along the
rostro-caudal axis
Variation in motor and inhibitory neuron identity based on
physiological and molecular properties is also observed
along the rostro-caudal body axis. At limb levels, distinct
motor neuron subsets project to flexor–extensor
muscles to drive such movements as running and
grasping, while at torso-levels, innervate hypaxial and
back musculature to control breathing, posture, and the
autonomic nervous system (reviewed in Dasen and
Jessell, 2009). Similarly, molecularly-distinct V1 subpopu-
lations exist at limb and torso levels with their function as
of yet unexplored (Francius et al., 2013; Sweeney et al.,
2018). To investigate whether such rostro-caudal differ-
ences in motor circuits might confer differential ALS sus-
ceptibility, we examined whether and to what extent
motor and V1 inhibitory neurons were lost at brachial
and thoracic levels of control and SODG93A mice at the
late CS5 stages of disease.
In agreement with previous studies in SODG93A mice
(Chiu et al., 1995), at late CS5 stages of disease, we
found that the magnitude of motor neuron loss at different
spinal levels varied significantly, with 58% lost at lumbar
levels, 41% at brachial levels, and 26% at thoracic levels
(Fig. 4A). The decreased susceptibility of thoracic motor
neurons can largely be explained by the resistance of
the autonomic subpopulation to degeneration (Fig. S3),
a finding observed previously in both SODG93A mice
(Chiu et al., 1995) and human ALS patients (Wetts and
Vaughn, 1996). Once this motor neuron population is
accounted for, somatic motor neurons are equally
affected along the entire rostro-caudal axis, with 50%
lost at all spinal cord levels (Figs. 4A, C and S3). In a
manner similar to somatic motor neurons, V1 inhibitory
neuron loss also occurred to an equal extent along the
entire rostro-caudal axis, with an 40% reduction at all
spinal cord levels (Fig. 4B, C). This result may indicate
that V1 inhibitory neuron loss is more associated with
somatic than with autonomic motor neuron loss.
Given the variation in motor output and circuit identity
along the body axis, we evaluated whether V1 subtypes
might differ in susceptibility based on rostro-caudal
position by refining our analysis to the V1 clades. We
found at all spinal cord levels that neurons in the
V1FoxP2 clade were lost to the same extent (Fig. 4D),
and those in the V1Pou6f2 and V1vCalbindin clades were
largely unaffected (Fig. 4F, G). However, the V1Sp8
clade varied in susceptibility by level in SODG93A mice:
at limb levels, V1Sp8 neurons decreased in number by
35%, while at thoracic levels, they did not significantly
differ in number (Fig. 4E). These findings support a
functional relationship between motor and V1 subsets at
different positions along the rostro-caudal axis, with
such a relationship potentially underlying differences in
ALS circuit susceptibility.V1 inhibitory – motor neuron synaptic connectivity at
early stages of ALS
The results above show that V1 inhibitory neurons are not
lost in substantial numbers at early stages of disease,
suggesting that an early loss of V1 inhibitory neurons is
not an initial cause of motor neuron loss. However, even
though V1 neurons are still present, their synaptic
contacts onto motor neurons could be disrupted at
these earlier stages and lead to motor neuron
dysfunction. To examine this possibility, we evaluated
the number of V1 synaptic contacts made directly onto
the cell body of motor neurons, first in control and then
SODG93A mice.
To provide a baseline for our analysis of SODG93A
mice, we first quantified the total (V1) and Renshaw
(V1Calbindin) synaptic contacts onto motor neuron cell
bodies in control mice. V1 synaptic contacts were
scored at p110 by counting the number of En1::Cre
driven TdTomato+/VGAT+ boutons on the cell bodies
of ChAT+ motor neurons in the lumbar spinal cord
(Fig. 5A, B). As shown previously (Alvarez et al., 2005),
ChAT+ motor neuron cell bodies at lumbar levels had
an average number of 0.07 synapses per micrometer.
Nearly every TdTomato+ bouton was VGAT+
(Fig. S4A, B), leading us to score only TdTomato in sub-
sequent experiments. We then further subdivided V1
synaptic contacts onto motor neuron cell bodies based
on Calbindin immunoreactivity and dorso-ventral position
in the spinal cord. This enabled us to score the number of
total (V1), Renshaw (V1Calbindin), and non-Renshaw
(V1Non-Calbindin) contacts. As shown previously (Carr
et al., 1998; Bikoff et al., 2016), we found that Renshaw
cells make up only a small portion of total V1 synaptic
contacts onto motor neuron cell bodies, and that these
V1Calbindin contacts are more numerous on ventral (20%
of total V1 contacts) than dorsal motor neurons (5%)
(Fig. 5B).
We then determined whether the number of V1
synaptic contacts onto motor neuron cell bodies varied
in control and SODG93A mice. We focused our analysis
on the early CS1-2 timepoint, when motor neurons have
not yet been lost in dramatic numbers (Fig. 2) but have
begun to express markers of stress (10% ATF3+) and
cell death (10% cCasp3+) (Fig. S2). To eliminate
variation due to cell-to-cell differences in disease state,
we restricted our analysis to motor neurons that are
actively stressed (Fig. S4C; ATF3-positive) or dying
(Fig. S4D; cleaved Casp3-positive) in SODG93A mice. At
these early stages of disease, these stressed or dying
motor neurons are likely to be of an alpha fast-fatigue or
fast-fatigue resistant subtype(Lalancette-Hébert et al.,
2016), and thus, for comparison, we scored the corre-
sponding large sized motor neurons in control animals.
We found that the total V1 synaptic contacts onto the cell
bodies of stressed or dying motor neurons were similar
(dorsal and middle) or increased significantly (ventral) in
SODG93A versus control mice (Fig. 5C). This increase in
ventral V1 to motor neuron cell body contacts occurred
for both Calbindin+ (Fig. 5D), consistent with previous
reports (Wootz et al., 2013), and Calbindin V1 synaptic
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Fig. 5. Analysis of V1 to motor neuron synapses in control and SODG93A mice at early disease stages. (A) Representative images in control mice of
lumbar motor neurons (ChAT, green) with V1 synaptic contacts (En1.TdTomato, red) that are either positive (V1Calbindin; asterisk) or negative
(V1Non-Calbindin; arrowhead) for Calbindin staining (magenta). Inserts in left panels of a single motor neuron are magnified in the right panel. Scale
bar = 10 mm. (B) Graphs depict mean ± sem synapse number per micron in control mice of total V1 or V1Calbindin synaptic contacts with ventral,
middle or dorsal motor neurons (n= 111 motor neurons in three control adult mice with an average age of P110). Data were separated by the
ventral (squares), middle (triangles) and dorsal (circles) position of motor neurons within the ventral horn. (C) Quantification of V1 synaptic contacts
with motor neurons that are stressed (SOD ATF3+; P= 0.0.0087) or dying (SOD cCasp3+; P= 0.0207) in CS1–2 SODG93A (SOD) versus
healthy motor neurons in control (CTL) mice. Data were separated based on motor neuron position as in (B). (D–E) Data shown in panel (C) are
separated out into V1Calbindin (D) and V1Non-Calbindin (E) synaptic contacts. In SOD vs CTL mice, V1Non-Calbindin synaptic contacts are significantly
increased on ventral motor neurons that are stressed (P= 0.0186) or dying (P= 0.0259) while V1Calbindin synaptic contacts are significantly
increased only on ventral motor neurons that are stressed (P= 0.0368) but not dying (P= 0.6126). Data were separated based on motor neuron
position as in (C). Graphs depict mean ± sem synapse number per micrometer of 66 ATF3+ and 61 cCasp3+ cells from five CS1–2 SODG93A
mice (mean ± stdev age = 111 ± 2 postnatal days).
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Taken together, these data indicate that not only
Renshaw cell but total V1 synaptic contacts onto motorFig. 4. Motor and inhibitory neuron loss along the rostro-caudal axis of spin
Total motor neurons (A) and V1 inhibitory neurons (B) are decreased in CS5 S
and lumbar (L3–5) spinal cord levels. Scatter dot plots represent average n
Fig. 1. P values <0.001 for all comparisons. (C) Percentage loss of motor or
at CS5. Scatter dot plots (top) or graph (bottom) of percent decrease in mean
age- and gender-matched pair. Graphs depict percent loss of brachial (blue),
V1 inhibitory neurons (y-axis). (D–G) Analysis of the V1 clades at brachial (
control mice at CS5. V1FoxP2 inhibitory neurons (D) are similarly reduced in
39% decrease) and lumbar (P< 0.001, 49% decrease) levels. V1Sp8 inhibitor
lumbar (P= 0.0087, 45% decrease) but not thoracic (P= 0.0919) levels.
P= 0.1975) and V1vCalbindin ((G): brachial, P= 0.7732; thoracic, P= 0.2898
Scatter dot plots represent average neuron number per 25 lm hemi-section
3
neuron cell bodies increase on stressed and dying motor
neurons in SODG93A mice, arguing against a premature
loss of V1 synapses.al cord in control and SODG93A mice at late stages of disease. (A, B)
ODG93A compared to control mice at brachial (C4–6), thoracic (T4–6)
euron number per 25 lm hemi-section as described in the legend to
V1 inhibitory neurons at brachial, thoracic or lumbar spinal cord levels
SODG93A v. CTL neuron number. Each dot represents a single litter-,
thoracic (green) and lumbar (red) total motor neurons (x-axis) versus
C4–6), thoracic (T4–6) and lumbar (L3–5) levels in SODG93A versus
number at brachial (P= 0.003, 43% decrease), thoracic (P= 0.006,
y neurons (E) are reduced at brachial (P= 0.007, 38% decrease) and
V1Pou6f2 ((F): brachial, P= 0.0915; thoracic, P= 0.2619; lumbar,
; lumbar, P= 0.3603) inhibitory neurons are unaffected at all levels.
as described in the legend to Fig. 1.
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Increasing evidence suggests that deficits in motor output
in ALS result not only from the initial loss of motor neurons
but also from more widespread alteration of modulatory
circuits that control their firing (van Zundert et al., 2012;
King et al., 2016; Brownstone and Lancelin, 2018). Such
alterations have not only been observed for spinal motor
circuits, as we demonstrate here for the V1 inhibitory neu-
ron class, but also for cortical motor circuits, in which
compensatory changes and/or degeneration of cortical
pre-motor subtypes occur (Zhang et al., 2016; Clark
et al., 2017). Like motor neuron loss, these interneuron
losses appear to be subtype-specific with certain classes,
and even subpopulations within these classes, most
affected—as we demonstrate here for the V1 clades
and a clade-derived subpopulation. This growing evi-
dence of selective, circuit-level changes raises several
fundamental questions about the mechanisms that initiate
and propagate ALS pathology, including what the origin is
of ALS susceptibility, and whether a functional relation-
ship exists between ALS-susceptible motor and interneu-
ron subtypes in both the normal and diseased state.
Selective loss of spinal interneurons
We show here that subsets of spinal interneurons are lost
in the SODG93A mouse model of ALS at late stages of
disease. Our data support the idea that like motor
neurons, V1 and V2a interneurons have an increased
susceptibility compared to other interneuron classes.
Approximately half of V1 inhibitory and a quarter of V2a
excitatory neurons are preserved, even in the most
affected animals, suggesting the existence of resistant
interneuron subpopulations, akin to the gamma subclass
of motor neurons. Examination of V1 inhibitory
subpopulations lends further support to this idea, as V1
clades and clade-derived subsets vary further in their
susceptibility. Such differences in susceptibility may
derive from differences in the downstream molecular
profiles, connectivity or function of individual V1
subpopulations. We cannot completely exclude however
that sampling biases due to variant subpopulation size
or rostro-caudal distribution could also contribute to
different levels of susceptibility. Moreover, clades that
are unaffected in cell number could exhibit subtle
alterations in health or synaptic connectivity, not
detected by our current analysis. Additionally, because
V1 clades comprise only half of total V1 inhibitory
neurons, how the other half may differ in ALS
susceptibility remains an open question. These
observed and potential differences in V1 susceptibility
mirror those of motor neurons, raising the question of
how the two might be causally related during disease
progression in ALS.
Potential mechanisms of selective interneuron
susceptibility
Our results also raise the question of what underlies the
differences we observe in spinal interneuron
susceptibility, across all interneuron types and within theV1 subclass. It is noteworthy that the loss of V2a
excitatory neurons we observe mirrors the timing and
severity of motor neuron loss at both early and late
stages of disease progression in SOD G93A mice. The
Chx10-expressing V2a excitatory neurons that we
examine are known to make extensive direct synapses
with motor neurons (Hayashi et al., 2018), and this direct
connectivity could drive V2a loss either as a consequence
of loss of their synaptic partners or through a trans-
synaptic spreading of the disease, as has been previously
been proposed for the focal spread of human ALS
(Ravits, 2014). Such a ‘‘direct-connectivity” model would
predict that neurons require their postsynaptic partner
for survival during ALS progression. A more detailed time
course analysis of markers of degeneration in connected
neurons, with higher spatial and temporal resolution and
in combination with genetic or viral ablation of one of
the two interconnected subpopulations, could shed light
on the potential for degenerative, trans-synaptic spread.
In contrast to the matching of V2a and motor neuron
degeneration, the loss of V1 inhibitory neurons is less
than that of motor neurons during disease progression.
At both early and late stages, the relative magnitude of
motor neuron loss is greater than that of V1 loss on
average and even within the same SODG93A mouse.
One potential explanation of this incongruence is that
V1 inhibitory neurons, unlike V2a excitatory neurons,
may have variant patterns of connectivity with motor
neurons, such that some are directly connected
whereas others influence motor neuron output through
indirect, multi-synaptic connections, and thus are less
affected. For example, the most susceptible V1FoxP2
subpopulation includes Ia-inhibitory interneurons that
regulate flexor–extensor coordination by directly
connecting to motor neurons of antagonist muscle pairs
(Benito-Gonzalez and Alvarez, 2012). Alternatively, V1
susceptibility may derive from connections to susceptible
motor neurons. For example, the resistance of V1Pou6f2
and thoracic V1Sp8 inhibitory neurons may stem from
the fact that these connect only with ALS-resistant motor
neuron types.
This model, however, is at odds with the relative
resistance of the Renshaw cell, a V1 subpopulation
making direct synaptic contact on ALS susceptible
motor neurons. Our data indicate that the loss of
Renshaw cells is less pronounced than other V1
subpopulations in later stage ALS animals, although a
previous report found a marked reduction in this
population at even more severe disease stages (Wootz
et al., 2013). The delayed susceptibility of the Renshaw
cell subpopulation, despite their known direct connectivity
to susceptible motor neurons, may reflect the specific
properties of this V1 class. Renshaw cells are unique in
their morphology, connectivity and intrinsic physiological
properties (Alvarez and Fyffe, 2007), and are the only
V1 inhibitory neuron that both receives input from and
synapses onto motor neurons. Renshaw cells additionally
express abundant calcium binding proteins, including Cal-
bindin and Parvalbumin, and use both GABA and glycine
inhibitory neurotransmitters, properties that have been
correlated with the resistance of neuronal subtypes in
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1994; Appel et al., 2001; Lorenzo et al., 2006; Clark
et al., 2017). Thus, the resistance of Renshaw cells may
instead result from intrinsic resilience to disease-
mediated degeneration.
This idea that intrinsic cellular properties might confer
a greater susceptibility or resistance of some neuron
classes compared to others also can be extended to the
V1 clades, as they are by definition different in their
transcriptional profiles. The consequences of these
transcriptional signatures on cellular properties, while
still largely unexplored, may include differences in
neurotransmitter (GABA, Glycine, and GABA/Glycine),
calcium binding proteins (Parvalbumin, Calbindin and
Calretinin), or other intrinsic properties. On an
anatomical level, V1 size and morphology could
additionally vary between clades or differentially
susceptible subpopulations and, on a physiological level,
V1 inhibitory neurons at early postnatal stages exhibit
markedly different active and passive membrane
properties (Bikoff et al., 2016). Whether and how such
intrinsic differences may contribute to selective suscepti-
bility will become clearer as intrinsic properties are better
defined for V1 clades under wildtype conditions. Our find-
ing that the transcription factors that mark clades and
clade-derived subtypes in early postnatal stages are con-
served in their mutual exclusivity, cell body positioning,
and relative numbers at adult stages lends some support
to the idea that these subpopulations have different con-
nectivity and functional properties that make them differ-
entially susceptible to ALS.
V1 synaptic connectivity and ALS progression
Understanding how the changes we observe in spinal
interneurons may influence motor neuron synaptic
connectivity is crucial to unravel the role of motor
circuits in ALS progression. Compensatory mechanisms
to maintain circuit homeostasis have been proposed to
explain the delay of any phenotypic symptoms of ALS
until stages when greater than one third of motor
neurons are lost. More specifically, such a
compensatory mechanism has been suggested for
Renshaw cells at the level of the synapse, wherein new
Renshaw cell contacts onto motor neuron cell bodies
appear at early stages of disease (Wootz et al., 2013).
This finding suggests that inhibitory neurons at first may
provide a protective effect by compensating for changes
in motor neuron excitability and then, as they themselves
degenerate, hasten disease progression and motor neu-
ron loss—a model of circuit homeostasis (Brownstone
and Lancelin, 2018).
Our analysis suggests that this homeostatic
phenomenon is not restricted to Renshaw cells but may
be a general feature of V1 inhibitory circuits, with total
V1 synaptic contacts, both Calbindin-negative and
Calbindin-positive, increasing on the cell bodies of
stressed or dying motor neuron in SODG93A mice
(Fig. 5). In fact, this increase in V1 synaptic number
onto motor neuron cell bodies during disease
progression is largely due to Calbindin-negative V1
inhibitory neurons, as they make up the bulk of directinhibitory synapses in both a normal and diseased state.
Several questions remain to be explored including
whether this increase in cell body synaptic contacts
occurs across the entire dendritic tree, whether it differs
for each V1 clade, and how it may modulate motor
neuron activity. Nonetheless, in a similar manner, an
early increase in synaptic contacts has also been
observed for the cholinergic V0c class (reviewed in
Witts et al., 2014) and has yet to be explored for the exci-
tatory V2a class, suggestive that modulation of synapse
numbers occurs for other non-inhibitory neurons and rais-
ing the larger question of how the inhibitory-excitatory
synaptic balance may be maintained or lost during ALS
progression. Disruption of the inhibitory-excitatory synap-
tic balance at different disease stages and/or for different
neuron types has the potential to contribute to the
observed hypo or hyper-excitability phenotypes proposed
to exacerbate ALS disease pathology (Van Den Bosch
et al., 2006; de Martı́nez-Silva et al., 2018). A more
detailed analysis of the inhibitory and excitatory circuits,
and their relationship to motor neuron loss in ALS, is likely
to be critical for understanding, and perhaps someday
slowing, disease progression.ACKNOWLEDGEMENTS
This work was made possible by the generous support of
Project ALS. Imaging and related analyses were
facilitated by The Waitt Advanced Biophotonics Center
Core at the Salk Institute, supported by grants from
NIH-NCI CCSG (P30 014195) and NINDS Neuroscience
Center (NS072031). The authors would like to
additionally thank Drs. Jane Dodd, Robert Brownstone,
and Laskaro Zagoraiou for helpful comments on the
manuscript. This manuscript is dedicated to Tom
Jessell, an inspirational scientist, friend and mentor.REFERENCES
Al-Chalabi A, Hardiman O (2013) The epidemiology of ALS: a
conspiracy of genes, environment and time. Nat Rev Neurol
9:617–628.
Alexianu ME, Ho BK, Mohamed AH, La Bella V, Smith RG, Appel SH
(1994) The role of calcium-binding proteins in selective
motoneuron vulnerability in amyotrophic lateral sclerosis. Ann
Neurol 36:846–858.
Alvarez FJ, Fyffe REW (2007) The continuing case for the Renshaw
cell. J Physiol (Lond) 584:31–45.
Alvarez FJ, Jonas PC, Sapir T, Hartley R, Berrocal MC, Geiman EJ,
Todd AJ, Goulding M (2005) Postnatal phenotype and localization
of spinal cord V1 derived interneurons. J Comp Neurol
493:177–192.
Appel SH, Beers D, Siklos L, Engelhardt JI, Mosier DR (2001)
Calcium: the Darth Vader of ALS. Amyotroph Lateral Scler Other
Motor Neuron Disord 2(Suppl 1):S47–S54.
Benito-Gonzalez A, Alvarez FJ (2012) Renshaw cells and Ia inhibitory
interneurons are generated at different times from p1 progenitors
and differentiate shortly after exiting the cell cycle. J Neurosci
32:1156–1170.
Bikoff JB, Gabitto MI, Rivard AF, Drobac E, Machado TA, Miri A,
Brenner-Morton S, Famojure E, Diaz C, Alvarez FJ, Mentis GZ,
Jessell TM (2016) Spinal inhibitory interneuron diversity
delineates variant motor microcircuits. Cell 165:207–219.
94 A. Salamatina et al. / Neuroscience 450 (2020) 81–95Brownstone RM, Lancelin C (2018) Escape from homeostasis: spinal
microcircuits and progression of amyotrophic lateral sclerosis. J
Neurophysiol 119:1782–1794.
Carr PA, Alvarez FJ, Leman EA, Fyffe RE (1998) Calbindin D28k
expression in immunohistochemically identified Renshaw cells.
Neuroreport 9:2657–2661.
Chang Q, Martin LJ (2009) Glycinergic innervation of motoneurons is
deficient in amyotrophic lateral sclerosis mice: a quantitative
confocal analysis. Am J Pathol 174:574–585.
Chiu AY, Zhai P, Dal Canto MC, Peters TM, Kwon YW, Prattis SM,
Gurney ME (1995) Age-dependent penetrance of disease in a
transgenic mouse model of familial amyotrophic lateral sclerosis.
Mol Cell Neurosci 6:349–362.
Clark RM, Blizzard CA, Young KM, King AE, Dickson TC (2017)
Calretinin and Neuropeptide Y interneurons are differentially
altered in the motor cortex of the SOD1G93A mouse model of
ALS. Sci Rep 7:44461–44513.
Crone SA, Quinlan KA, Zagoraiou L, Droho S, Restrepo CE, Lundfald
L, Endo T, Setlak J, Jessell TM, Kiehn O, Sharma K (2008)
Genetic ablation of V2a ipsilateral interneurons disrupts left-right
locomotor coordination in mammalian spinal cord. Neuron
60:70–83.
Dasen JS, Jessell TM (2009) Hox networks and the origins of motor
neuron diversity. Curr Top Dev Biol 88:169–200.
Ericson J, Rashbass P, Schedl A, Brenner-Morton S, Kawakami A,
van Heyningen V, Jessell TM, Briscoe J (1997) Pax6 controls
progenitor cell identity and neuronal fate in response to graded
Shh signaling. Cell 90:169–180.
Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-
Sanchez A, Khan J, Polak MA, Glass JD (2004) Amyotrophic
lateral sclerosis is a distal axonopathy: evidence in mice and man.
Exp Neurol 185:232–240.
Francius C, Harris A, Rucchin V, Hendricks TJ, Stam FJ, Barber M,
Kurek D, Grosveld FG, Pierani A, Goulding M, Clotman F (2013)
Identification of multiple subsets of ventral interneurons and
differential distribution along the rostrocaudal axis of the
developing spinal cord Winkler C, ed.. PLoS ONE 8:e70325.
Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P (2000) Early
and selective loss of neuromuscular synapse subtypes with low
sprouting competence in motoneuron diseases. J Neurosci
20:2534–2542.
Gabitto MI, Pakman A, Bikoff JB, Abbott LF, Jessell TM, Paninski L
(2016) Bayesian sparse regression analysis documents the
diversity of spinal inhibitory interneurons. Cell 165:220–233.
Gosgnach S, Bikoff JB, Dougherty KJ, Manira El A, Lanuza GM,
Zhang Y (2017) Delineating the diversity of spinal interneurons in
locomotor circuits. J Neurosci 37:10835–10841.
Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander
DD, Caliendo J, Hentati A, Kwon YW, Deng HX (1994) Motor
neuron degeneration in mice that express a human Cu, Zn
superoxide dismutase mutation. Science 264:1772–1775.
Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G,
Robberecht W, Shaw PJ, Simmons Z, van den Berg LH (2017)
Amyotrophic lateral sclerosis. Nat Rev Dis Primers
3:17085–17091.
Hayashi M, Hinckley CA, Driscoll SP, Moore NJ, Levine AJ, Hilde KL,
Sharma K, Pfaff SL (2018) Graded Arrays of spinal and
supraspinal V2a interneuron subtypes underlie forelimb and
hindlimb motor control. Neuron 97. 869.e5–884.e5.
Herron LR, Miles GB (2012) Gender-specific perturbations in
modulatory inputs to motoneurons in a mouse model of
amyotrophic lateral sclerosis. Neuroscience 226:313–323.
Hossaini M, Cardona Cano S, van Dis V, Haasdijk ED, Hoogenraad
CC, Holstege JC, Jaarsma D (2011) Spinal inhibitory interneuron
pathology follows motor neuron degeneration independent of glial
mutant superoxide dismutase 1 expression in SOD1-ALS mice. J
Neuropathol Exp Neurol 70:662–677.
Kanning KC, Kaplan A, Henderson CE (2010) Motor neuron diversity
in development and disease. Annu Rev Neurosci 33:409–440.
Kaplan A, Spiller KJ, Towne C, Kanning KC, Choe GT, Geber A, Akay
T, Aebischer P, Henderson CE (2014) Neuronal matrixmetalloproteinase-9 is a determinant of selective
neurodegeneration. Neuron 81:333–348.
Kaur SJ, McKeown SR, Rashid S (2016) Mutant SOD1 mediated
pathogenesis of amyotrophic lateral sclerosis. Gene
577:109–118.
King AE, Woodhouse A, Kirkcaldie MTK, Vickers JC (2016)
Excitotoxicity in ALS: overstimulation, or overreaction? Exp
Neurol 275(Pt 1):162–171.
Konsolaki E, Koropouli E, Pothakos K, Zagoraiou L, submitted for
consideration in this issue. Neuroscience.
Lorenzo L-E, Barbe A, Portalier P, Fritschy J-M, Bras H (2006)
Differential expression of GABAA and glycine receptors in ALS-
resistant vs. ALS-vulnerable motoneurons: possible implications
for selective vulnerability of motoneurons. Eur J Neurosci
23:3161–3170.
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